Disclosures for "Analysis of Real-world Characteristics of Patients with CDKL5 Deficiency Disorder Enrolled for Ganaxolone Treatment"
-
Dr. Flatt has received personal compensation for serving as an employee of Marinus Pharmaceuticals. An immediate family member of Dr. Flatt has received personal compensation for serving as an employee of Pfizer . Dr. Flatt has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for The Jason Foundation, Inc.. Dr. Flatt has stock in Marinus Pharmaceuticals.
-
Dr. Aimetti has received personal compensation for serving as an employee of Marinus Pharmaceuticals.
-
Dr. Miller has received personal compensation for serving as an employee of Marinus Pharmaceuticals. Dr. Miller has stock in Marinus Pharmaceuticals.